PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsCholine c-11
Choline c-11
Choline C-11 (choline c-11) is a small molecule pharmaceutical. Choline c-11 was first approved as Choline c-11 on 2012-09-12.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Choline c-11 (discontinued: Choline c-11)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Choline c-11
Tradename
Company
Number
Date
Products
CHOLINE C-11Mayo Clinic PET Radiochemistry FacilityN-203155 RX2012-09-12
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
choline c 11New Drug Application2024-12-17
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
Code
Description
A9515
Choline c-11, diagnostic, per study dose up to 20 millicuries
Clinical
Clinical Trials
29 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471—C61441—1119
AdenocarcinomaD000230————1—12
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hepatocellular carcinomaD006528—C22.0—1——12
Liver neoplasmsD008113EFO_1001513C22.0—1——12
HypersensitivityD006967EFO_0003785T78.40—1———1
CarcinomaD002277—C80.0—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
RecurrenceD012008——1———23
Esophageal neoplasmsD004938—C151————1
LymphangioleiomyomatosisD018192—J84.811————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HyperparathyroidismD006961EFO_0008506E21.3————33
Primary hyperparathyroidismD049950EFO_0008519E21.0————22
AdenomaD000236——————11
Brain neoplasmsD001932EFO_0003833C71————11
GliomaD005910EFO_0000520—————11
Alzheimer diseaseD000544EFO_0000249F03————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCholine c-11
INN_
Description
(11)C-choline chloride is a quaternary ammonium salt that is the chloride salt of (11)C-choline. An intravenous radioactive diagnostic agent used as a tracer during positron emission tomography scans to help detect sites of recurrent prostate cancer. It has a role as a radioactive tracer, a radioactive imaging agent and a diagnostic agent. It is a chloride salt, a quaternary ammonium salt and an (11)C-modified compound. It contains an (11)C-choline.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
C[N+](C)([11CH3])CCO.[Cl-]
Identifiers
PDB—
CAS-ID87591-54-6
RxCUI—
ChEMBL IDCHEMBL2095207
ChEBI ID72321
PubChem CID—
DrugBank—
UNII IDM4AS4XGD4Q (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 13 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use